Company intelligence / Profile preview

Vitaccess

Oxford, England, United Kingdomvitaccess.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vitaccess specializes in generating patient-centered real-world evidence using its proprietary digital platform. The company has supported numerous observational and outcomes studies across rare diseases and chronic conditions, providing data for clinical trials, health technology assessments, and reimbursement submissions. Their work has contributed to peer-reviewed publications and regulatory submissions.

Therapeutic areas: OncologyPulmonologyNeurologyHematology
Modalities: Non-pharmacological therapy (focus on digital data collection and real-world evidence; not a drug developer)
Industry: Contract Research Organization

Partnerships

PharnextCollaborations with European biopharma companies, US-based biotechs, patient advocacy groups, clinicians worldwide

Beyond the preview

Go deeper on Vitaccess.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitaccess.

Explore the full profile